English 
Chinese
SmartDose® 3.5 Injector
Leading the way with integrated containment and delivery solutions
The first combination product that incorporates the SmartDose® 3.5 Injector has been approved by the U.S. Food and Drug Administration (FDA). The SmartDose injector offers a wearable, subcutaneous injector with an integrated drug delivery system that incorporates human factors and usability testing to deliver a truly patient-centric approach to self-administration.
PRECISE. RELIABLE. READY TO GO.
Patient Centric Wearable Injector
- User loaded, subcutaneous self-administration
- Ability to deliver high volume and high viscosity drug products
- Connectivity capable
- Easy to use, intuitive design
- Visual, tactile and audible feedback to boost user confidence
- Training solutions available for a seamless onboarding experience
Flexible Technology
- Address a variety of delivery times through adaptable, pre-programmable technology
- Enables less painful injections through pre-programmable delivery times
- Multiple published studies* indicate lower pain with customizable delivery rates
- Installed capacity at multiple manufacturing sites
- Regulatory, Quality and Human Factors expertise to support your development
Technical Specifications
Downloadable Resources
SmartDose® is a registered trademark of West Pharma. Services IL, Ltd., a subsidiary of West Pharmaceutical Services, Inc.
Flurotec® is a registered trademark of Daikyo Seiko, Ltd.”
SelfDose™ is a trademark of West Pharmaceutical Services, Inc.
